Are you Dr. Masliah?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 31 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
Ucsd Medical Center
200 West Arbor Drive M/C 8201
San Diego, CA 92103Phone+1 619-543-5719Fax+1 619-543-3183
Summary
- Dr. Eliezer Masliah, MD is a pathologist in San Diego, California. He is currently licensed to practice medicine in California. He is affiliated with UC San Diego Medical Center - Hillcrest and is a Professor at UCSD School of Medicine.
Education & Training
Universidad Nacional Autonoma de MexicoClass of 1984
Certifications & Licensure
CA State Medical License 1999 - 2026
Publications & Presentations
PubMed
- Corrigendum to "Neurogranin binds alpha-synuclein in the human superior temporal cortex and interaction is decreased in Parkinson's disease" [Brain Res. 1591 (2014) 10...Andrew O Koob, Gideon M Shaked, Andreas Bender, Alejandro Bisquertt, Edward Rockenstein
Brain Research. 2025-03-15 - Retraction Note: Neuroprotective effects of Cerebrolysin in triple repeat Tau transgenic model of Pick's disease and fronto-temporal tauopathies.Edward Rockenstein, Kiren Ubhi, Michael Mante, Jazmin Florio, Anthony Adame
BMC Neuroscience. 2025-03-10 - Retraction Notice to "Differential effects of immunotherapy with antibodies targeting α-synuclein oligomers and fibrils in a transgenic model of synucleinopathy" [Neur...Omar El-Agnaf, Cassia Overk, Edward Rockenstein, Michael Mante, Jazmin Florio
Neurobiology of Disease. 2025-03-01
Press Mentions
A Top Government Scientist Engaged in Research Misconduct, NIH FindsSeptember 26th, 2024- It’s in the BloodAugust 9th, 2024
- A Promising Trial Targets a Genetic Risk for Alzheimer’sDecember 2nd, 2022
- Join now to see all
Grant Support
- Alzheimers Disease Project: Neuroimmune responses and therapeutics of alpha-synucleinopathies of the aging populationNATIONAL INSTITUTE ON AGINGPresent
- Alzheimers Disease Project: Neuroimmune responses and therapeutics of alpha-synucleinopathies of the aging populationNATIONAL INSTITUTE ON AGINGPresent
- Alzheimers Disease Project: Neuroimmune responses and therapeutics of alpha-synucleinopathies of the aging populationNATIONAL INSTITUTE ON AGINGPresent
